Baumol, W. J. (1967); “Macroeconomics of unbalanced growth: the anatomy of urban crisis”, American Economic Review, 57(3): 415-26.

Brus, D. (1998); “Baumol’s Disease in the Netherlands”, Bureau for Economic Policy Analysis, Policy Paper; No. 4.

Central Bank of Islamic Republic of Iran (2011); Data Bank for Economical Time Series.

Fuchs, V. (1968); The Service Economy, New York and London: Colombia University Press.

Gerdtham, U., Soogard, J., Andersson, F., Jönsson, B. (1992); “Econometric analysis of health care expenditure: a cross-section study of the OECD countries”. Journal of Health Economics, 11(1): 63-84.

Getzen, T. (2000); “Health care is an individual necessity and a national luxury: applying multilevel decision models to the analysis of health care expenditures”, Journal of Health Economics, 19(2): 259-70.

Hartwig, J. (2008); “What drives health care expenditure? – Baumol’s model of ‘unbalanced growth Journal of Health Economics, 27 (3): 603-623.

Hartwig, J. (2008); “Has health capital formation cured ‘Baumol’s Disease’? Swiss Economic Institute 2008; Working paper No. 206.

Hartwig, J. (2011); “Can Baumol’s model of unbalanced growth contribute to explaining the secular rise in health care expenditure? An alternative test”, Applied Economics, 43 (2): 173-184.

Işcan, T. (2010); “How much can Engel's law and Baumol's disease explain the rise of service employment in the United States?” The B.E. Journal of Macroeconomics, 10 (1): 26-59.

Johansen, S. (1995); “Likelihood Based Inferences in Cointegrated Vector Autoregressive Models”. Oxford: Oxford University Press; 1995.

Nordhaus, W. (2008); “Baumol's diseases: A macroeconomic perspective”, The B.E. Journal of Macroeconomics, 8(1): Article 9.

Organization for Economic Cooperation and Development (2006); “Projecting OECD health and long-term care expenditures: What are themain drivers?” OECD Economics Department; Working Paper No. 477.

Pomp, M and Vujic, S. (2008); “Rising health spending, new medical technology and the Baumol effect”, Netherlands Bureau for Economic Policy Analysis, Discussion paper No. 115.

Roberts, J. (1999); “Sensitivity of elasticity estimates for OECD health care spending: Analysis of a dynamic heterogeneous data field”, Health Economics, 8(5): 459-72.

Seshamani, M., Gray, A. M. (2004); “Ageing and health-care expenditure: the red herring argument revisited”, Health Economics, 13(4): 303-14.

The World Bank (2013); “World Development Indicators”, USA: Washington DC.

Triplett, J. and Bosworth, B. (2003); “Productivity Measurement Issues in Service Industries: Baumol’s Disease Has Been Cures”, Economic Policy Review, Issue Sep: 23-33.

United Nations (2011); “World Population Ageing: 1950-2050”, United Nations Population Division. USA: New York.

Wilson, R. M. (1999); “Medical care expenditures and GDP growth in OECD nations”, American Association of Behavioral and Social Sciences Journal, 2: 159-71.

Zweifel, P., Felder, S., Meier, M. (1999); “Ageing of population and health care expenditure: a red herring?” Health Economics, 8(6): 485-96.

Zweifel, P., Felder, S., Meier, M. (2004); “Population ageing and health care expenditure: new evidence on the ‘red herring’?” Geneva Papers on Risk and Insurance, 29(4):652-66.